Progress of Antiangiogenic Drug-induced Renal Injury
10.3971/j.issn.1000-8578.2021.20.0807
- VernacularTitle:抗血管生成靶向药物相关性肾脏损伤的研究进展
- Author:
Qingyan FENG
1
;
Jinsheng XU
;
Yaling BAI
Author Information
1. Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
- Publication Type:Research Article
- Keywords:
Antiangiogenic drugs;
Adverse reaction;
Renal injury;
Biomarkers
- From:
Cancer Research on Prevention and Treatment
2021;48(4):424-428
- CountryChina
- Language:Chinese
-
Abstract:
With the continuous development of precision targeting medicine, antiangiogenic drugs have achieved good therapeutic effects in the treatment of advanced cancer, but renal injury and other adverse reactions often occur during the use, which reduce the quality of life of patients. This article reviews the mechanism of renal injury induced by antiangiogenic drugs and the potential relation between renal injury and prognosis.
